Deven Choksey says, "Coal India is expected to report higher numbers due to sustained elevated levels of production and better realization from the open options market. Overall the balance sheet looks relatively more positive than what we have seen up till now. Mid-tier pharma companies are also expected to show better performance, particularly those with specialty product portfolios such as Cipla and Sun Pharma."